PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1152002
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1152002
Global Psoriasis Therapeutics Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Psoriasis is a type of skin disorders which causes skins cells to replace more quickly than normal. Psoriasis is associated with immune system and most commonly occurs on knees, elbows, trunk, and scalp. The increasing incidences of Psoriasis disease and rising awareness towards different treatment options available as well as strategic initiatives from leading market players are key factors accelerating the market growth.
According to National Psoriasis Foundation, USA - as of 2020, around 8 million individuals in the United States are affected by Psoriasis. In addition, around 125 million people worldwide suffers from Psoriasis, witnessing for over 2 to 3 percent of the global population. Moreover, as per World Health Organization (WHO) estimates - approximately 100 million individuals worldwide are affected by Psoriasis. Also, rising healthcare infrastructure in emerging economies and increasing R&D activities in pharmaceuticals sector would create lucrative growth prospectus for the market over the forecast period. However, high treatment cost associated with Psoriasis treatment and health risks associated with medications impede the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Psoriasis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the; leading region in terms of market share owing to presence of leading market players as well as increasing prevalence of Psoriasis in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising pharmaceuticals sector as well as increasing incidences of skin disorders in the region.
Major market players included in this report are:
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck and Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G and W Laboratories Inc.
Recent Developments in the Market:
Global Psoriasis Therapeutics Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Drug Class, Molecule Type, Route of Administration, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
By Molecule Type
Biologics
Small Molecules
By Route of Administration
Oral
Parenteral
Topical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable